BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8417011)

  • 21. Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms.
    Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Masuda K; Kato M
    J Neurol Sci; 1996 Mar; 136(1-2):169-73. PubMed ID: 8815166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 'Prefrontal' cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation.
    Vernaleken I; Buchholz HG; Kumakura Y; Siessmeier T; Stoeter P; Bartenstein P; Cumming P; Gründer G
    Hum Brain Mapp; 2007 Oct; 28(10):931-9. PubMed ID: 17133402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 6-[18F]fluoro-L-dopa uptake and [76Br]bromolisuride binding in the excitotoxically lesioned caudate-putamen of nonhuman primates studied using positron emission tomography.
    Hantraye P; Loc'H C; Maziere B; Khalili-Varasteh M; Crouzel C; Fournier D; Yorke JC; Stulzaft O; Riche D; Isacson O
    Exp Neurol; 1992 Feb; 115(2):218-27. PubMed ID: 1531196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography in Parkinson's disease: glucose and DOPA metabolism.
    Martin WR; Stoessl AJ; Adam MJ; Ammann W; Bergstrom M; Harrop R; Laihinen A; Rogers JG; Ruth TJ; Sayre CI
    Adv Neurol; 1987; 45():95-8. PubMed ID: 3103398
    [No Abstract]   [Full Text] [Related]  

  • 25. Brain 6-[18F]fluorodopa metabolism in early and late onset of Parkinson's disease studied by positron emission tomography.
    Nagasawa H; Tanji H; Itoyama Y; Saito H; Kimura I; Fujiwara T; Iwata R; Itoh M; Ido T
    J Neurol Sci; 1996 Dec; 144(1-2):70-6. PubMed ID: 8994106
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of intrastriatal ratios of FDOPA to differentiate idiopathic Parkinson's disease from atypical parkinsonian disorders.
    Jaimini A; Tripathi M; D'Souza MM; Panwar P; Sharma R; Mehta S; Pandey S; Saw S; Singh D; Solanki Y; Mishra AK; Mondal A
    Nucl Med Commun; 2013 May; 34(5):426-31. PubMed ID: 23458855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data.
    Burn DJ; Sawle GV; Brooks DJ
    J Neurol Neurosurg Psychiatry; 1994 Mar; 57(3):278-84. PubMed ID: 8158173
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A within-subject comparison of 6-[18F]fluoro-m-tyrosine and 6-[18F]fluoro-L-dopa in Parkinson's disease.
    Gallagher CL; Christian BT; Holden JE; Dejesus OT; Nickles RJ; Buyan-Dent L; Bendlin BB; Harding SJ; Stone CK; Mueller B; Johnson SC
    Mov Disord; 2011 Sep; 26(11):2032-8. PubMed ID: 21638324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dual time point method for the quantification of irreversible tracer kinetics: A reference tissue approach applied to [
    Lopes Alves I; Meles SK; Willemsen AT; Dierckx RA; Marques da Silva AM; Leenders KL; Koole M
    J Cereb Blood Flow Metab; 2017 Sep; 37(9):3124-3134. PubMed ID: 28156211
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transplantation of fetal dopamine neurons in Parkinson's disease: PET [18F]6-L-fluorodopa studies in two patients with putaminal implants.
    Sawle GV; Bloomfield PM; Björklund A; Brooks DJ; Brundin P; Leenders KL; Lindvall O; Marsden CD; Rehncrona S; Widner H
    Ann Neurol; 1992 Feb; 31(2):166-73. PubMed ID: 1575455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine.
    Deep P; Dagher A; Sadikot A; Gjedde A; Cumming P
    Synapse; 1999 Dec; 34(4):313-8. PubMed ID: 10529725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder.
    Ernst M; Zametkin AJ; Matochik JA; Pascualvaca D; Jons PH; Cohen RM
    Am J Psychiatry; 1999 Aug; 156(8):1209-15. PubMed ID: 10450262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Striatal function in normal aging: implications for Parkinson's disease.
    Sawle GV; Colebatch JG; Shah A; Brooks DJ; Marsden CD; Frackowiak RS
    Ann Neurol; 1990 Dec; 28(6):799-804. PubMed ID: 2126684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anatomic and biochemical correlates of the dopamine transporter ligand 11C-PE2I in normal and parkinsonian primates: comparison with 6-[18F]fluoro-L-dopa.
    Poyot T; Condé F; Grégoire MC; Frouin V; Coulon C; Fuseau C; Hinnen F; Dollé F; Hantraye P; Bottlaender M
    J Cereb Blood Flow Metab; 2001 Jul; 21(7):782-92. PubMed ID: 11435790
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of [18F]fluorodopa (FDOPA) kinetics in the brain of healthy volunteers after acute haloperidol challenge.
    Vernaleken I; Kumakura Y; Cumming P; Buchholz HG; Siessmeier T; Stoeter P; Müller MJ; Bartenstein P; Gründer G
    Neuroimage; 2006 May; 30(4):1332-9. PubMed ID: 16439159
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fluorodopa positron emission tomography with an inhibitor of catechol-O-methyltransferase: effect of the plasma 3-O-methyldopa fraction on data analysis.
    Ishikawa T; Dhawan V; Chaly T; Robeson W; Belakhlef A; Mandel F; Dahl R; Margouleff C; Eidelberg D
    J Cereb Blood Flow Metab; 1996 Sep; 16(5):854-63. PubMed ID: 8784230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.
    Ma Y; Feigin A; Dhawan V; Fukuda M; Shi Q; Greene P; Breeze R; Fahn S; Freed C; Eidelberg D
    Ann Neurol; 2002 Nov; 52(5):628-34. PubMed ID: 12402261
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Net influx of plasma 6-[18F]fluoro-L-DOPA (FDOPA) to the ventral striatum correlates with prefrontal processing of affective stimuli.
    Siessmeier T; Kienast T; Wrase J; Larsen JL; Braus DF; Smolka MN; Buchholz HG; Schreckenberger M; Rösch F; Cumming P; Mann K; Bartenstein P; Heinz A
    Eur J Neurosci; 2006 Jul; 24(1):305-13. PubMed ID: 16882026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of preclinical Parkinson's disease with PET.
    Brooks DJ
    Geriatrics; 1991 Aug; 46 Suppl 1():25-30. PubMed ID: 1909983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The identification of presymptomatic parkinsonism: clinical and [18F]dopa positron emission tomography studies in an Irish kindred.
    Sawle GV; Wroe SJ; Lees AJ; Brooks DJ; Frackowiak RS
    Ann Neurol; 1992 Nov; 32(5):609-17. PubMed ID: 1449241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.